echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Huadong Medicine metformin and Enpagliflozin tablets (I) obtained the drug registration certificate

    Huadong Medicine metformin and Enpagliflozin tablets (I) obtained the drug registration certificate

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the 8th, Huadong Medicine announced that its wholly-owned subsidiary, Zhongmei Huadong, received the approval of the State Food and Drug Administration for the issuance of the "Drug Registration Certificate" for metformin and enpagliflozin tablets (I)
    .

    Metformin is a biguanide oral hypoglycemic drug
    .


    Metformin Enpagliflozin Tablets is a compound of two hypoglycemic drugs with complementary mechanisms of action.


    Up to now, in addition to the original research company, only one company in East China, China and the United States has obtained the registration certificate for metformin and enpagliflozin tablets
    .


    According to the query of the IQVIA database, the global sales of this product in 2020 will be 505 million U.


    As of the date of this announcement, the company's accumulated direct R&D investment for metformin and enpagliflozin tablets was approximately RMB 18.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.